HSD3B7 and hyperinsulinemic hypoglycemia, familial, 4: Although most patients with HSD3B7 deficiency showed good compliance to CDCA therapy, there were seven patients that did not respond to therapy, presumed to be due to the intrinsic hepatotoxicity of CDCA.